ampio pharmaceuticals stock target price

Get a real-time Ampio Pharmaceuticals Inc. In the Pharmaceutical Products industry ALZN ALT and ALPN are the three stocks most similar to Ampio Pharmaceuticals Inc regarding the price target and analyst recommendation.

6 Stocks To Watch Marketwatch

The Companys lead product candidate is Ampion which contains a blood-derived cyclized peptide and small molecules that target multiple pathways in the innate immune response.

. The average twelve-month price target for Ampio Pharmaceuticals is 450 with a high price target of 450 and a low price target of 450. Ad Learn How Bayer Uses Digital Technologies Strives for Innovative Healthcare Solutions. NYSEAMERICANAMPE Get Rating was the target of unusually large options trading on ThursdayStock investors purchased 4789 call options on the stock.

AMPE analyst stock forecast price target and recommendation trends with in-depth analysis from research. The analyst firm set a price target for 400 expecting AMPE to rise to within 12. The most common way Ampio Pharmaceuticals analysts use to provide recommendation to the public is financial statements.

The average price target is 4 which means analysts expect the stock to rise by 83023 over the next twelve months. Stock quote stock chart quotes analysis advice financials and news for share AMPIO PHARMACEUTICALS INC. Find the latest Ampio Pharmaceuticals Inc.

APH Börse Stuttgart. The latest price target for Ampio Pharmaceuticals AMEX. AMPE updated stock price target summary.

According to analysts consensus price target of 450 Ampio Pharmaceuticals has a forecasted upside of 10057 from its current price of 041. Analyst ratings historical stock prices earnings estimates actuals. 1 day agoNYSE AMPE traded up 001 on Wednesday hitting 041.

AMPE stock quote history news and other vital information to help you with your stock trading and investing. Ampio Pharmaceuticals started at buy with 450 stock price target at Alliance Global Partners. AMPE stock price quote with breaking news financials statistics charts and more.

In the context of stocks in the small market cap category Ampio Pharmaceuticals Incs upside potential average analyst target price relative to current price is greater than 9443 of them. Raymond James boosted their target price on Apellis Pharmaceuticals from 11200 to 11400 and gave the stock a strong-buy rating in a report on Tuesday March 1st. AMPE was reported by Roth Capital on December 19 2019.

That average ranking earns Ampio Pharmaceuticals Inc an Analyst Rating of 73 which is better than 73 of stocks based on data compiled by InvestorsObserver. Ampio has traded between 39 cents and 2 over a 52-week period. According to 1 Wall Street analyst that have issued a 1 year AMPE price target the average AMPE price target is 450 with the highest AMPE stock price forecast at 450 and the lowest AMPE stock price forecast at 450.

Explore the Latest Trends Driving Innovation in Pharma What Bayer is Doing With Them. The stock was up 537 at 66 cents at time of. Alliance Global Partners analyst James Molloy initiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a 450.

What is AMPEs Price Target. The current projected Ampio Pharmaceuticals target price consensus is 40 with 1 analyst opinions. The stock had a trading volume of 1332915 shares compared to its average volume of 1792847.

Ampio Pharmaceuticals Inc. Amount of Analyst Coverage Ampio Pharmaceuticals has only been the subject of 1 research reports in the past 90 days. Ampio Pharmaceuticals has a 52-week low of.

Dow Jones a News Corp company About WSJ. 3 rows AMPE has a higher average analyst price target than 316 of Pharmaceutical Products stocks. According to the issued ratings of 1 analysts in the last year the consensus rating for Ampio Pharmaceuticals stock is Buy based on the current 1 buy rating for AMPE.

Find the latest Ampio Pharmaceuticals Inc. The current analyst and expert consensus on Ampio Pharmaceuticals is Strong Buy with 0 strong sell and 1 strong buy opinions. Is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions.

Learn more on AMPEs analyst rating history. AMPE Price Action. The 2 analysts offering 12-month price forecasts for Ampio Pharmaceuticals Inc have a median target of 425 with a high estimate of 450 and a low.

Stocknews Com Initiates Coverage On Ampio Pharmaceuticals Nyse Ampe Defense World